Characterization of intragenic tandem duplication in the PAFAH1B1 gene leading to isolated lissencephaly sequence by Satoru Takahashi et al.
Takahashi et al. Molecular Cytogenetics  (2015) 8:84 
DOI 10.1186/s13039-015-0186-8CASE REPORT Open AccessCharacterization of intragenic tandem
duplication in the PAFAH1B1 gene leading
to isolated lissencephaly sequence
Satoru Takahashi*, Ryosuke Tanaka, Satomi Okano, Akie Okayama, Nao Suzuki and Hiroshi AzumaAbstract
Background: Genetic aberrations in PAFAH1B1 result in isolated lissencephaly sequence (ILS), a neuronal migration
disorder associated with severe mental retardation and intractable epilepsy. Approximately 60 % of patients with ILS
show a 17p13.3 deletion or an intragenic variation of PAFAH1B1 that can be identified by fluorescence in situ
hybridization (FISH) analysis or gene sequencing. Using multiplex ligation-dependent probe amplification (MLPA),
40–80 % of the remaining patients show small genomic deletions or duplications of PAFAH1B1. The intragenic
duplications within PAFAH1B1 are predicted to abolish the PAFAH1B1 function, although a detailed characterization
of the duplication regions have not been reported.
Results: Here we describe a female patient with ILS occurring predominantly in the posterior brain regions. MLPA
was used to identify a small duplication within PAFAH1B1. This result was confirmed by array-based comparative
genomic hybridization analysis, revealing a duplication of the 29-kb region encompassing putative regulatory
elements and exon 2 of PAFAH1B1. The region was characterized as an intragenic tandem duplication by
sequencing, revealing a 28-bp microhomology sequence at the breakpoint junctions. Parental genetic testing
confirmed that the tandem duplication occurred de novo. Reverse transcription-PCR on RNA extracted from
peripheral blood leukocytes revealed that the expression level of PAFAH1B1 decreased to that in a patient with
Miller-Dieker syndrome, a contiguous gene-deletion disorder characterized by classical lissencephaly and a facial
dysmorphism.
Conclusions: This study expanded the spectrum of PAFAH1B1 variants and identified a unique genomic
architecture including microhomology sequences in PAFAH1B1 underlying an intragenic tandem duplication leading
to ILS.
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Classical lissencephaly is a brain malformation resulting
from impaired neuronal migration. The condition is char-
acterized by absent (agyria) or decreased (pachygyria) con-
volutions of the cerebral cortex, causing the brain surface
to appear smooth. Lissencephaly occurs either as part of
Miller–Dieker syndrome (MDS), a multiple malformation
syndrome with severe grade lissencephaly and a character-
istic facial dysmorphism, or as an isolated condition with-
out peculiar facial features termed isolated lissencephaly* Correspondence: satoru5p@asahikawa-med.ac.jp
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tions in either the PAFAH1B1 gene on chromosome
17p13.3 or the DCX gene on chromosome Xp22.3 [2, 3].
PAFAH1B1 variations result in more severe abnormalities
in the posterior brain regions, whereas DCX variations
cause more severe abnormalities in the anterior brain re-
gions [4, 5]. MDS is caused by a deletion of genes in
chromosome 17p13.3, which at minimum includes the
PAFAH1B1 and YWHAE genes [6].
The PAFAH1B1 gene (also known as LIS1) spans
approximately 92-kb and contains 11 exons, the first of
which is noncoding. The cDNA contains a 1230-bp-long
coding sequence and encodes a 410-amino-acid polypep-
tide with a calculated molecular mass of 45 kDa.icle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Brain MRI scan of a patient with an intragenic tandem
duplication in the PAFAH1B1 gene. Axial T2-weighted brain image
indicating the occurrence of predominant agyria in the posterior
regions, and pachygyria in the anterior regions. The patient was
diagnosed with grade 3 lissencephaly
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motility by controlling the function of the cytoplasmic
dynein motor protein and plays an important role in
neuronal migration during brain development [7].
Here, we describe a case of a Japanese patient with ILS
who had an intragenic tandem duplication of the region
encompassing the putative regulatory elements and exon
2 of the PAFAH1B1 gene. We characterized the bound-
ary of the duplication region and found that each of the
duplicated regions was flanked by an identical 28-bp se-
quence. The 28-bp microhomology potentially repre-




The patient, 4 years old at the time of this writing, is a
Japanese female and the first child of nonconsanguineous
parents. She was born at 40 weeks of gestation after an
uneventful pregnancy with a birth weight of 2780 g, a
length of 46 cm, and a head circumference of 32 cm (50th
percentile). At the age of 2 months, she developed her first
clonic seizures in the right arm. The tonic or clonic sei-
zures also occurred in one or both limbs in the left side of
her body. During the next 2 weeks, the polymorphous
focal seizures became more frequent, occurring in clusters
of 30–40 times a day. At the age of 3 months, she was re-
ferred to our hospital. Neurological examination revealed
muscle hypotonia and a profound delay in psychomotor
development. The patient had no eye contact and was not
able to control her head. The hematological and chemical
work-up was normal. Magnetic resonance imaging (MRI)
of the brain demonstrated a thickened cortex and gyral
malformations that were more severe in the posterior
brain regions than in the anterior brain regions (Fig. 1).
The patient did not show the characteristic facial ap-
pearance seen in patients with MDS. Therefore, on
the basis of neuroradiological test results, she was di-
agnosed with ILS.
The patient’s interictal electroencephalography (EEG)
results indicated low-amplitude background activity over
the posterior head regions and multifocal spikes. Ictal
recordings revealed focal, rhythmic theta activities origin-
ating from the right or left parietal regions and eventually
spreading to the ipsilateral hemisphere.
Valproic acid treatment was initiated but was unsuc-
cessful in controlling her seizures. In the next 2 weeks,
the spasms appeared in clusters, and her interictal EEG
results showed hypsarrhythmia. The patient’s condition
was found to evolve to West syndrome. Treatment with
synthetic adrenocorticotropic hormone (ACTH) was
started wherein a single daily dose of 0.0125 mg/kg was
administrated for 14 consecutive days, with subsequent
tapering. The patient’s spasms ceased by day 6 of theACTH therapy but reappeared during the withdrawal
stage. Her psychomotor development was severely
delayed without head control, eye pursuit, or the use of
meaningful words. Because of feeding problems resulting
from difficulties in swallowing, she was fed via a gastros-
tomy tube.
Results
The patient exhibited an abnormal gyral pattern charac-
terized by agyria in the posterior brain regions and
pachygyria in the anterior brain regions. These charac-
teristics are highly suggestive of PAFAH1B1 gene varia-
tions [4]. Fluorescence in situ hybridization (FISH)
results for the 17p13.3 region and direct sequencing of
the PAFAH1B1 gene revealed no abnormalities in this
patient. Therefore, we analyzed the patient’s PAFAH1B1
gene via multiplex ligation-dependent probe amplifica-
tion (MLPA) and identified a duplication of the region
encompassing exon 2, but not exon 1 or 3 (Fig. 2). This
result was confirmed by array-based comparative genomic
hybridization (array CGH) analysis. The size of the dupli-
cation region was approximately 29 kb, spanning positions
chr17:2,513,432 to 2,539,559 (GRCh37/hg19; Fig. 3a). To
define the boundary of the duplication region, long-range
polymerase chain reaction (PCR) was performed based on
the array CGH and MLPA results. PCR performed using a
forward primer in intron 2 and a reverse primer in intron

















Fig. 2 MLPA analysis performed on DNA from the patient revealed a small duplication in PAFAH1B1 that included exon 2. Results indicate the
relative peak area of a probe target sequence with normalization against normal female samples and are shown as the means ± SD (n = 3)
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ents’ genomic DNA (Fig. 3b), confirming that the duplica-
tion was intragenic and in tandem. These results further
indicated that the duplication occurred de novo in the
patient. Sequencing analysis of the PCR product revealed
that each of the duplicated regions was flanked by an






















Fig. 3 Intragenic tandem duplication in the PAFAH1B1 gene in a patient w
log2 intensity ratios of the patient versus reference DNA. A 29-kb duplicatio
PAFAH1B1 gene on chromosome 17p13.3. b Schematic representation of th
was performed with the intron2F and intron1R primers, which yielded a 15
parents’ genomic DNA. These results indicated that the tandem duplication
region of identical sequences (28 nucleotides enclosed by black line) at themicrohomology was used to generate the tandem duplica-
tion (Fig. 3c).
Reverse transcription (RT)-PCR amplification with a
forward primer in exon 1 and a reverse primer in exon 3
yielded two fragments with different lengths of 314-bp
and 536-bp from the RNA of the patient, but only a











tron2F − intron 1R
tron1F − intron 2R
M
ith isolated lissencephaly sequence. a Array-CGH results showing the
n (purple-shaded region with green dots) was detected within the
e duplicated region with the primer-binding sites. Long-range PCR
69-bp PCR product from the patient’s genomic DNA, but not from her
occurred de novo. c Sequencing analysis of the PCR product revealed










exon 1 exon 2 exon 3
exon 1 exon 2 exon 3exon 2

















Fig. 4 Decreased expression of PAFAH1B1 in a patient with isolated lissencephaly sequence (ILS). a RT-PCR on RNA extracted from peripheral
blood leukocytes revealed that the expression levels of PAFAH1B1, but not YWHAE, were decreased in this patient, while the expression levels of
both the genes were decreased in a patient with Miller-Dieker syndrome (MDS). Note that a longer PAFAH1B1 mRNA (536 bp) was present in the
patient with ILS at a low level along with the normal mRNA (314 bp). The quantitative results in the bar graph indicate PAFAH1B1 and YWHAE
mRNA expression levels, relative to those of controls, and are shown as the mean ± SD (n = 3). Data are expressed in arbitrary units. b Sequencing
analysis of the longer PAFAH1B1 transcript found in the patient confirmed the tandem duplication of exon 2
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the transcript contained a tandem duplication of exon 2
(Fig. 4b). The PAFAH1B1 variant showed low-level ex-
pression (Fig. 4a). The expression level of the normal
PAFAH1B1 transcript in the patient decreased to that in
a patient with MDS (Fig. 4a).
Discussion
Previous studies using MLPA have identified 30 deletions
and 7 duplications within the PAFAH1B1 gene among 57
patients with ILS occurring predominantly in the posterior
brain regions, in whom FISH for 17p13.3 and gene se-
quencing gave negative results [8, 9]. These intragenic
duplications are predicted to abolish the PAFAH1B1 func-
tion, although a detailed characterization of the duplica-
tion regions has not been reported. Here, we report our
findings for a patient with posteriorly dominant ILS who
had an intragenic tandem duplication in the PAFAH1B1
gene. The PAFAH1B1 expression level decreased to that
in a patient with MDS. Analysis of the duplication bound-
ary revealed a microhomology at the breakpoint, which
suggested that the duplication might have been mediated
in part by the microhomology sequence.A recent report described the presence of microho-
mology sequences ranging from 2 to 75-bp in 79 % of
the breakpoint junctions of rare pathogenic copy num-
ber variations (CNVs) [10]. These results indicate that
rare pathogenic CNVs are caused by a replication-based
mechanism of mitotic origin mediated by microhomol-
ogy sequences in the context of local genomic architec-
tures. Our investigation of the breakpoint region of the
intragenic tandem duplication revealed a 28-bp micro-
homology sequence in introns 1 and 2 of the PAFAH1B1
gene. In addition, the observation of no additional
sequence changes at the junction indicates that the du-
plication resulted from a single replication-based event.
Genetic testing of the patient’s parents confirmed that
the tandem duplication variant occurred de novo. Thus,
a single event of microhomology-mediated rearrange-
ment might be the potential molecular mechanism
whereby the tandem duplication variant occurred.
A gradient of severity in lissencephaly can aid the
planning of appropriate genetic testing. ILS occurring
predominantly in the posterior brain regions is most fre-
quently associated with PAFAH1B1 variants, but rarely
with variants of the TUBA1A gene encoding tubulin
Takahashi et al. Molecular Cytogenetics  (2015) 8:84 Page 5 of 6alpha-1a [11]. We did not analyze the TUBA1A gene
because the patient showed no additional malformations,
such as cerebellar hypoplasia or the absence of the
corpus callosum, which have been found in patients with
TUBA1A-associated lissencephaly [11]. The duplication
region identified in this patient includes putative non-
coding regulatory elements of PAFAH1B1 and its second
exon, which harbors the ATG translational start site.
The mutant mRNA containing the tandem exon 2 dupli-
cation showed low-level expression. The 5′-untranslated
region (5′-UTR) contains a variety of cis-regulatory
elements which influences the expression of the down-
stream genes. Hence, this duplication potentially affected
PAFAH1B1 expression through destabilizing the second-
ary structure of the 5′-UTR. A balanced chromosomal
translocation that disrupted the 5′-UTR of the PAFAH1B1
gene has been found in a patient with lissencephaly [12].
The heterozygous deletion of YWHAE, together with
PAFAH1B1 in patients with MDS, is known to increase
the severity, usually with grade 1 lissencephaly (diffuse
agyria) being observed [6]. The patient in this study
showed decreased expression of PAFAH1B1, but not
YWHAE, resulting in grade 3 lissencephaly (mixed agyria
and pachygyria).Conclusions
Our findings expanded the spectrum of PAFAH1B1 vari-
ants implicating in ILS. We observed a heterozygous in-
tragenic tandem duplication involving the putative
noncoding regulatory elements and exon 2 of PAFAH1B1,
which resulted in decreased expression of this gene in a
patient with ILS. We further found a unique genomic
architecture including microhomology sequences in in-
trons 1 and 2 of the PAFAH1B1 gene underlying an intra-
genic tandem duplication leading to ILS.
Methods
Mutation screening
This study was performed in compliance with the guide-
lines of Asahikawa Medical University. After obtaining
written informed consent from her parents, genomic
DNA was extracted from the peripheral blood leukocytes
of both the patient and her parents, and was used for vari-
ant screening. Appropriate primers were used to yield
DNA fragments spanning the entire coding region and in-
tron–exon boundaries of PAFAH1B1 [5]. The PCR frag-
ments were analyzed by automated sequencing. Gene
dosage analysis was performed using the SALSA MLPA
Kit P061-B1 Lissencephaly (MRC-Holland, Amsterdam,
The Netherlands). To define the boundary of the dupli-
cated region, array CGH analysis was performed using a
high-resolution 1 M array (Agilent Technologies Inc.;
Santa Clara, CA).Long-range PCR amplification and DNA sequencing
analysis
Long-range PCR was performed using TaKaRa LA
Taq Polymerase (TaKaRa Bio Inc.; Otsu, Japan).
Primers were designed for amplification and sequencing
of the duplication junction within PAFAH1B1 including a
forward primer in intron 2 (intron2F; 5′-GTGTGGAAG
ACACTTAGTGGC-3′) and a reverse primer in intron 1
(intron1R; 5′-GGCCTACATCCTGACTTGAC-3′). To
verify the DNA quality for PCR amplification, the follow-
ing primers for amplification of PAFAH1B1 exon 2 were
also used: a forward primer in intron 1 (intron1F; 5′- TG
TGGAAGACACTTAGTGGCA-3′) and a reverse primer
in intron 2 (intron2R; 5′- AAGAGACCTCCCAAAGCTG
TA-3′), which generated a 269-bp product [5]. The
obtained PCR products were directly sequenced on an
ABI 3130 Genetic Analyzer (Applied Biosystems; Foster
City, CA).
RNA isolation and RT-PCR
Total RNA was extracted from the peripheral blood
leukocytes using the PAXgene Blood RNA Kit (Qiagen
GmbH; Hilden, Germany). The RT step was performed
using the SuperScript First-Strand Synthesis System
(Invitrogen Corporation; Carlsbad, CA) to generate
cDNA by using 1 μg of total RNA in a 20-μl reaction.
The following primers were used: for PAFAH1B1, 5′-GA
GTGAAGGACGGAAGAGGC-3′ and 5′-GAATATGC
CTCTTCATAGCC-3′, generating a 314-bp product; for
YWHAE, 5′-ACGACGAAATGGTGGAGT-3′ and 5′-A
GCTGCTGGAATGAGGTG-3′, generating a 278-bp
product; and for GAPDH, 5′-CCAGCCGAGCCACATC
GCTC-3′ and 5′-ATGAGCCCCAGCCTTCTCCAT-3′,
generating a 360-bp product. The PCR products were
visualized by ethidium bromide staining, following elec-
trophoresis on 2 % agarose gels. The optical densities of
the bands were quantified using an image analysis sys-
tem and ImageJ software (National Institutes of Health;
Bethesda, MD). Selected RT-PCR products were subse-
quently cloned into the pCR4-TOPO vector (Invitrogen
Corporation; Carlsbad, CA) for sequencing.
Consent
Written informed consent was obtained from the parents
of the patients for publication of this case report. A copy
of the written consent is avaible by the Editor-in –chief of
this journal.
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